| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 47.310 | 75.245 | 87.325 | 91.084 | 56.359 | 58.690 | 81.211 | 78.244 | 88.397 | 108.251 |
| Total Income - EUR | 47.440 | 75.270 | 87.328 | 91.085 | 56.416 | 61.208 | 81.214 | 78.246 | 88.472 | 108.326 |
| Total Expenses - EUR | 27.517 | 33.330 | 44.645 | 45.958 | 29.772 | 36.236 | 33.802 | 34.546 | 40.730 | 49.257 |
| Gross Profit/Loss - EUR | 19.923 | 41.940 | 42.683 | 45.127 | 26.644 | 24.972 | 47.411 | 43.700 | 47.742 | 59.069 |
| Net Profit/Loss - EUR | 18.500 | 41.187 | 41.810 | 44.216 | 26.080 | 24.587 | 46.664 | 42.933 | 46.874 | 56.176 |
| Employees | 4 | 6 | 7 | 5 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Adonis Medsan Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 4.332 | 3.998 | 3.718 | 3.441 | 3.171 | 2.910 | 2.652 | 2.486 | 2.304 | 2.118 |
| Current Assets | 22.610 | 45.909 | 49.152 | 51.135 | 44.026 | 38.177 | 57.367 | 76.311 | 50.727 | 60.853 |
| Inventories | 0 | 0 | 0 | 172 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 4.745 | 6.209 | 8.632 | 3.939 | 5.082 | 1.020 | 688 | 32.643 | 6.360 | 40.507 |
| Cash | 17.865 | 39.700 | 40.520 | 47.024 | 38.944 | 37.157 | 56.679 | 43.668 | 44.367 | 20.346 |
| Shareholders Funds | 21.292 | 43.951 | 44.527 | 47.096 | 28.695 | 27.153 | 49.173 | 45.450 | 49.383 | 58.671 |
| Social Capital | 90 | 89 | 88 | 86 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | 5.649 | 5.956 | 8.343 | 7.504 | 18.555 | 13.934 | 10.947 | 33.378 | 3.699 | 4.435 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Adonis Medsan Srl